Dec 17, 2015 7:05am EST Immunovaccine Publishes Findings Unique to DepoVax(TM) Technology on Potential of MRI Scans to Predict and Optimize Cancer Vaccine Response
Dec 02, 2015 7:05am EST Immunovaccine's DPX-Survivac Induces an Immune Response in Diffuse Large B Cell Lymphoma
Nov 12, 2015 5:05pm EST Immunovaccine Announces Financial Results for Quarter Ended September 30, 2015
Oct 29, 2015 7:05am EDT Immunovaccine's Vaccine Candidate for Respiratory Syncytial Virus Is Well Tolerated in Volunteers in Phase 1 Clinical Trial
Jul 15, 2015 10:47am EDT Immunovaccine's DPX-Survivac Receives Orphan Drug Designation from the FDA for the Treatment of Ovarian Cancer
Jul 08, 2015 7:05am EDT Immunovaccine and PharmAthene Sign Exclusive Worldwide License Agreement to Develop and Commercialize an Anthrax Vaccine Formulated in DepoVax(TM)
Jul 02, 2015 7:05am EDT Immunovaccine Publishes Clinical Results With DPX-Survivac in Combination With an Immune-Modulating Compound
